Phil Micans MS PharmB
Phil Micans studied Food & Vitamin Technology at South London College (now called Thames University) and afterward he completed an applied science bachelor’s degree in Pharmacy. He also holds a masters degree in biochemistry from Canterbury University.

Having been actively involved in the anti-aging field since the late 1980’s, Phil holds the positions of Editor-in-Chief of the Aging Matters™ Magazine, Director of Research and Development to IM Health (a biological age measurement system), Chairman of the Monte Carlo Antiaging Congress.

He is currently the Assistant Editor to the Lifespan Medicine Magazine (along with Thierry Hertoghe, M.D.) and is also an advisor to the British Longevity Society (founded by Dr. Marios Kyriazis), as well as the Stromboli conference on cancer and aging, (founded by Professor Walter Pierpaoli) and the London Antiageing Conference (patronaged by Heather Bird).

Phil realized that the information age has created a new generation of informed individuals and physicians who view things globally and want to obtain the best possible treatment based on a scientific perspective. As such, in 1991 he became a founding member of the IAS Group (International Antiaging Systems), where he maintains the position of Vice President responsible for research and development.

2012 - The need for antiageing medicine; who, why, what and when!

Many people realise that the world’s population is at the same time expanding and getting chronologically ‘older’ and that these issues present many challenges. This lecture aims to highlight the facts with a view to the cost of ‘mainstream’ medicine and a brief overview of the most likely possible answers- asking the question- is antiageing medicine the solution?

Many health care professionals in the preventative medicine field know that it offers many solutions, but perhaps lack the details of why it is actually necessary. This lecture will provide the interested attendee with the facts as issued by the US, UK and WHO authorities.

It will become clear that ‘mainstream’ medicine- as it exists today, cannot continue as-is and that a different path will need to be taken; therefore positioning antiageing as the most likely and sensible alternative, which should be the prerogative of all those who wish to be at the forefront of this new medicine for the next millennium.

In Phil’s indomitable style, he attempts, (slightly tongue in cheek at times) to challenge who, what, why and when antiageing medicine will be at the fore. For example, a quick assessment of who is ageing well, why we age, what the facts of the ageing populous are, plus when antiageing will fit into healthcare- with the concept of the optimal health pyramid- all these issues will be attempted to be covered.

References:

1. US department of health and human resources
2. US census bureau
3. World Health Organisation
4. UK department of health
5. Lehman brothers equity research
6. US healthcare and finance administrative